{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:03Z","timestamp":1786114923798,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030898","name":"Institut canadien d&apos;information sur la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacadv.2026.102937","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:30:07Z","timestamp":1784748607000},"page":"102937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Disease in Males With Breast Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Anjali","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Giannakeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deva","family":"Thiruchelvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle B.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.102937_bib1","doi-asserted-by":"crossref","first-page":"1270877","DOI":"10.3389\/fonc.2023.1270877","article-title":"Causes of death in women with breast cancer: a risks and rates study on a population-based cohort","volume":"13","author":"Contiero","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jacadv.2026.102937_bib2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/cncr.32648","article-title":"Causes of death after breast cancer diagnosis: a US population-based analysis","volume":"126","author":"Afifi","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jacadv.2026.102937_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jacc.2007.06.037","article-title":"Early breast cancer therapy and cardiovascular injury","volume":"50","author":"Jones","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2015.65.1505","article-title":"Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study","volume":"34","author":"Thavendiranathan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacadv.2026.102937_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/annonc\/mdw673","article-title":"Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khosrow-Khavar","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jacadv.2026.102937_bib7","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1056\/NEJMra1707939","article-title":"Breast cancer in men","volume":"378","author":"Giordano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.102937_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: a disease distinct from female breast cancer","volume":"173","author":"Gucalp","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jacadv.2026.102937_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1200\/JCO.19.03120","article-title":"Management of Male Breast Cancer: ASCO Guideline","volume":"38","author":"Hassett","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jacadv.2026.102937_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jacadv.2026.102937_bib11","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.102937_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","article-title":"An application of capture-recapture methods to the estimation of completeness of cancer registration","volume":"41","author":"Robles","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib13","first-page":"160","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records","volume":"33","author":"Schultz","year":"2013","journal-title":"Chronic Inj Can"},{"key":"10.1016\/j.jacadv.2026.102937_bib14","first-page":"e225","article-title":"Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative Data Linked Database (EMRALD)","volume":"26","author":"Tu","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jclinepi.2006.12.009","article-title":"ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions","volume":"60","author":"Vermeulen","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib16","first-page":"1388","article-title":"Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard","volume":"29","author":"Tu","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib17","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.25011\/cim.v44i2.36354","article-title":"Validation of diagnosis and procedure codes for revascularization for peripheral artery disease in Ontario administrative databases","volume":"44","author":"Jacob-Brassard","year":"2021","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jacadv.2026.102937_bib18","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.25011\/cim.v39i2.26483","article-title":"Validation of carotid artery revascularization coding in Ontario health administrative databases","volume":"39","author":"Hussain","year":"2016","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jacadv.2026.102937_bib19","first-page":"1561","article-title":"Identifying patients with atrial fibrillation in administrative data","volume":"32","author":"Tu","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacadv.2026.102937_bib20","first-page":"e18","article-title":"Accuracy of administrative databases in identifying patients with hypertension","volume":"1","author":"Tu","year":"2007","journal-title":"Open Med"},{"key":"10.1016\/j.jacadv.2026.102937_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12913-018-3148-0","article-title":"Identifying diabetes cases from administrative data: a population-based validation study","volume":"18","author":"Lipscombe","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacadv.2026.102937_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(11)60990-2","article-title":"Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study","volume":"378","author":"Gershon","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.102937_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2369-14-81","article-title":"Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes","volume":"14","author":"Fleet","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacadv.2026.102937_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-160105","article-title":"Identification of physician-diagnosed alzheimer\u2019s disease and related dementias in population-based administrative data: a validation study using family physicians\u2019 electronic medical records","volume":"54","author":"Jaakkimainen","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jacadv.2026.102937_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCOUTCOMES.114.001416","article-title":"The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services","volume":"8","author":"Tu","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacadv.2026.102937_bib26","first-page":"16","article-title":"Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients","volume":"30","author":"Brenner","year":"2009","journal-title":"Chronic Dis Can"},{"key":"10.1016\/j.jacadv.2026.102937_bib27","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/jama.2024.4970","article-title":"Accounting for competing risks in clinical research","volume":"331","author":"Austin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.102937_bib28","article-title":"The risk of heart-specific death in breast cancer patients","volume":"15","author":"Luo","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacadv.2026.102937_bib29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2147\/CIA.S314689","article-title":"Cardiovascular and other competing causes of death in Male breast cancer patients: a population-based epidemiologic study","volume":"16","author":"Zhang","year":"2021","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jacadv.2026.102937_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/curroncol30010023","article-title":"A prospective population-based study of cardiovascular disease mortality following treatment for breast cancer among men in the United States, 2000-2019","volume":"30","author":"Appiah","year":"2022","journal-title":"Curr Oncol Tor Ont"},{"key":"10.1016\/j.jacadv.2026.102937_bib31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/annonc\/mdr459","article-title":"Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects","volume":"23","author":"Pemmaraju","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jacadv.2026.102937_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#","article-title":"Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients","volume":"74","author":"Anelli","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jacadv.2026.102937_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3747\/co.v17i5.631","article-title":"Endocrine therapy for male breast cancer: rates of toxicity and adherence","volume":"17","author":"Visram","year":"2010","journal-title":"Curr Oncol Tor Ont"},{"key":"10.1016\/j.jacadv.2026.102937_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clbc.2013.09.001","article-title":"Contemporary systemic therapy for male breast cancer","volume":"14","author":"Bradley","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jacadv.2026.102937_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10549-017-4433-z","article-title":"Increased risk of arterial thromboembolism in older men with breast cancer","volume":"166","author":"Reiner","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jacadv.2026.102937_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41416-018-0369-2","article-title":"Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis","volume":"120","author":"Eggemann","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jacadv.2026.102937_bib37","article-title":"Cardiotoxicity in breast cancer treatment: causes and mitigation","volume":"37","author":"Valiyaveettil","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.jacadv.2026.102937_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaccao.2022.10.010","article-title":"The ESC cardio-oncology guidelines: a roadmap for clinical practice and generating needed evidence","volume":"5","author":"Sparano","year":"2023","journal-title":"JACC CardioOncol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26003583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26003583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:05:08Z","timestamp":1785971108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26003583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2772963X26003583"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102937","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disease in Males With Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102937"}}